Oral Medications: Complete List and References
Below is an exhaustive list of oral medications relevant to various dermatological conditions, serving as a reference resource associated with the DermNet NZ pages:
- Acyclovir
- Acitretin
- Acne Treatment
- Alitretinoin
- Amitriptyline
- Antiandrogens
- Antimalarials
- Antibiotics
- Antibiotics for Acne
- Anticholinergics
- Antihistamines
- Antimalarials
- Antioxidants
- Apremilast
- A biopsy may reveal deposits of
- Bexarotene
- Cannabinoids
- Chloroquine
- Cyclosporine
- Clindamycin
- Clofazimine
- Cobimetinib
- Colchicine
- Cyproterone
- Cyclophosphamide
- Dabrafenib
- Dapsone
- Erythromycin
- Ethinylestradiol / cyproterone
- Finasteride
- Fluconazole
- Fumaric Acid Esters
- Gabapentin
- Images of Pigmentary Lichen Planus
- Griseofulvin
- Hormone Therapy
- Horse Chestnut Extract
- Hydroxycarbamide
- Pigmentary lichen planus of the face
- Hydroxyurea
- Imatinib
- Demodex mites
- Itraconazole
- Ivermectin
- Ketoconazole
- Leflunomide
- Leukotriene Antagonists
- Melatonin
- Acne Management
- Melatonin
- Immunofluorescence staining can also be used to complement the study.
- Mycophenolate Mofetil
- Nicotinamide
- Oral Antifungal Medications
- Oral contraceptives
- Corticosteroids Oral
- Penicillin
- Posaconazole
- Potassium Iodide
- Propranolol
- Quinacrine
- Rifampicin
- Selenium
- Sirolimus
- Sonidegib
- Spironolactone
- Systemic
- Sulfasalazine
- Systemic Symptoms: Manifestations such as fever and malaise are absent or mild in EM, but are markedly prominent in SJS/TEN, especially during the
- Terbinafine
- Tetracycline
- Thalidomide
- Thioguanine
- Tranexamic Acid
- Treatment of Unlike other fungal
- Adjuvant supportive therapies for melanoma
- Vismodegib
- Vitamin A
- Voriconazole
The official and authoritative source for medication information, including approved uses and risk details, is the data sheets approved by New Zealand. It is essential to consult the corresponding individual data sheet on the Medsafe website.
